Page 2,627«..1020..2,6262,6272,6282,629..2,6402,650..»

Sigma Intros Stem Cell Medium

Posted: October 6, 2012 at 2:14 am

Sigma Life Science, the innovative biological products and services research wing of Sigma-Aldrich Corporation (SIAL), has announced the launch of Stemline pluripotent culture medium, a human pluripotent stem cell culture medium which provides a suitable environment for the long-term maintenance and growth of healthy pluripotent stem cells.

Sigma-Aldrich stated that the Stemline pluripotent stem cell culture medium is serum-free, consists of fully-defined components and has 80% less basic fibroblast growth factor compared to the leading pluripotent stem cell culture medium. This provides a favorable environment for long-term maintenance of optimal growth rates, viability and pluripotency.

The stem cell research community usually complains of the high costs of media for pluripotent stem cells. However, Sigma-Aldrichs Stemline pluripotent culture medium performs as good as the leading medium for maintaining pluripotency and optimal growth rates and is available at comparatively lower costs than the conventional media.

It is also found that cultured pluripotent stem cells show all the established pluripotency markers and maintain proper karyotype and the ability to distinguish into each of the three germ layers. The novel Stemline media strengthens Sigma-Aldrich's position as one of the largest global providers of cell culture media.

Sigma-Aldrich released its second-quarter 2012 results in July. The company posted adjusted earnings of 97 cents per share for the quarter, in line with the Zacks Consensus Estimate but ahead of the year-ago earnings of 93 cents per share. Profit, as reported, marginally increased year over year to $115 million or 94 cents per share.

Revenues rose 4% year over year to $664 million, aided by acquisitions. The company saw growth across its Research Chemicals and Fine Chemicals (SAFC) divisions in the quarter.

Sigma-Aldrich expects organic growth to be low-to-mid single digits in 2012. Macroeconomic uncertainties may hinder its Research Chemicals business whereas growth in Bioscience and Hitech is expected to drive SAFC sales in the remainder of the year. The acquisitions of BioReliance and Research Organics are expected to boost sales by 6%.

Sigma-Aldrich, a close peer of Bayer AG (BAYRY), currently maintains a Zacks #2 Rank, which translates into a short-term (1 to 3 months) Buy rating. We have a long-term (more than 6 months) Neutral recommendation on the stock.

Read the Full Research Report on BAYRY

Zacks Investment Research

Read the original:
Sigma Intros Stem Cell Medium

Posted in Stem Cell Research | Comments Off on Sigma Intros Stem Cell Medium

From Stem Cells To Mouse Eggs To Baby Mice – No Father Involved

Posted: October 6, 2012 at 2:14 am

Editor's Choice Academic Journal Main Category: Fertility Also Included In: Stem Cell Research Article Date: 05 Oct 2012 - 14:00 PDT

Current ratings for: From Stem Cells To Mouse Eggs To Baby Mice - No Father Involved

4.4 (5 votes)

5 (1 votes)

The scientists, from Kyoto University, first produced healthy mouse pups in 2011 using stem cell-derived sperm. They have now achieved the same by using eggs which were created in the same way.

Scientists are describing the Kyoto team's feat as a "significant achievement" which will have a profound impact on reproductive cell biology and genetics research.

In both cases, the scientists used ES (embryonic stem) cells and iPS (induced pluripotent stem) cells. ES are taken from embryos while iPS come from reprogrammed adult tissue cells that mimic stem cell behavior.

Theory suggests that both ES and iPS cells can produce all the cell types in the body. However, the majority of scientists have not been able to make them turn into germ cells, which eventually become eggs or sperm.

Mitinori Saitou and team hit upon a process that managed to turn stem cells into germ cells. They started off with ES and iPS cells and cultured them into a mix of proteins to produce primordial germ cell-like cells.

Their aim was to get precursor egg cells, known as oocytes. They mixed the primordial cells with fetal ovarian cells, and formed reconstituted ovaries which were grafted onto natural ovaries within live mice. Exactly four weeks and four days later, the primordial germ cell-like cells had turned into oocytes. The ovaries were removed from the mice and the oocytes harvested, fertilized in petri dishes, and the resulting embryos were implanted into surrogate mothers.

The rest is here:
From Stem Cells To Mouse Eggs To Baby Mice - No Father Involved

Posted in Stem Cell Research | Comments Off on From Stem Cells To Mouse Eggs To Baby Mice – No Father Involved

Dish-Grown Sperm and Eggs Produce Mouse Pups

Posted: October 5, 2012 at 7:19 pm

By Dennis Normile, ScienceNOW

Want baby mice? Grab a petri dish. After producing normal mouse pups last year using sperm derived from stem cells, a Kyoto University team of researchers has now accomplished the same feat using eggs created the same way. The study may eventually lead to new ways of helping infertile couples conceive.

This is a significant achievement that I believe will have a sustained and long-lasting impact on the field of reproductive cell biology and genetics, says Amander Clark, a stem cell biologist at University of California, Los Angeles.

The stem cells in both cases are embryonic stem (ES) cells and induced pluripotent stem (iPS) cells. The former are taken from embryos and the latter are adult tissue cells that are reprogrammed to act like stem cells. In theory, both can produce all of the bodys cell types, yet most researchers have been unable to turn them into germ cells, precursors of sperm and eggs.

The Kyoto group, led by stem cell biologist Mitinori Saitou, found a process that works. As with the sperm, the group started with ES and iPS cells and cultured them in a cocktail of proteins to produce primordial germ cell-like cells. To get oocytes, or precursor egg cells, they then mixed the primordial cells with fetal ovarian cells, forming reconstituted ovaries that they then grafted onto natural ovaries in living mice. Four weeks and 4 days later, the primordial germ cell-like cells had developed into oocytes. The team removed the ovaries, harvested the oocytes, fertilized them in vitro, and implanted the resulting embryos into surrogate mothers. About 3 weeks later, normal mouse pups were born, the researchers report online today in Science.

It is remarkable that one can produce oocytes capable of sustaining complete development starting with embryonic stem cells, says Davor Solter, a developmental biologist at Singapores Institute of Medical Biology. Clark adds that the immediate impact of the work will be on understanding the molecular mechanisms involved in forming germ cells. Saitou says that with a bit more progress in understanding the complex interactions at work, they may be able to coax the cells through the entire oocyte development process in a lab dish. If successful, we may be able to skip the grafting, he says.

Further in the future, the technique could lead to a new tool for treating infertility. This study has provided the critical proof of principle that oocytes can be generated from induced pluripotent stem cells, Clark says. If applied to humans, it could lead to the ability to create oocytes from iPS cells taken from infertile women. But Saitou cautions that moving on to human research will require resolving thorny ethical issues and technical difficulties. Solter says that at the extreme, the new approach could lead to the production of human embryos from cell lines and tissue samples. Still, he notes, defining the status of such parentless human embryos and the biological, ethical, and legal issues they will raise defies the imagination.

This story provided by ScienceNOW, the daily online news service of the journal Science.

See the article here:
Dish-Grown Sperm and Eggs Produce Mouse Pups

Posted in Stem Cells | Comments Off on Dish-Grown Sperm and Eggs Produce Mouse Pups

Stem cells: of mice and women?

Posted: October 5, 2012 at 7:19 pm

And rightly so: stem-cell scientists have derived many types of cells from stem-cell precursors, but have in the past struggled with sex cells. The research by a team at Kyoto University provides a powerful model into mammalian development and infertility, but it is still a long way off from being used in human therapy.

Despite this fact, it did not stop the headlines in some of today's press screaming that infertile women could one day become pregnant by creating eggs from stem cells.

Evelyn Telfer, a reproductive biologist at the University of Edinburgh, told me this study has no clinical application to humans whatsoever because the tissue used in this study were all foetal and not adult cells.

Mitinori Saitou led a team using foetal mouse tissue from embryos or skin cells to create stem cells. Those stem cells were then genetically reprogrammed to become germ cells egg precursor cells.

These were then given a cocktail of "factors" to support their growth into mature eggs. The eggs were fertilised by IVF in the lab and then implanted into surrogate mice. Three baby mice were born and grew into fertile adults.

The fact that artificially manufactured eggs have gone on to produce healthy mice which are fertile is absolutely astounding and a great step forward for science. The results are published in the journal, Science.

But there are huge differences between human and mouse cells, not to mention the medical and ethical issues surrounding human ovarian tissue to culture cells.

Further clinical trials would be necessary using adult mouse cells first before we can start projecting that we can manufacture babies, and scientists need to learn so much more about how women form eggs.

So while this is major contribution to the field of reproductive biology, the study is not a ready-made cure for women with fertility problems.

Originally posted here:
Stem cells: of mice and women?

Posted in Stem Cells | Comments Off on Stem cells: of mice and women?

K computer may be used in regenerative medicine

Posted: October 5, 2012 at 7:19 pm

The Yomiuri Shimbun/Asia News Network Friday, Oct 05, 2012

The K supercomputer, which once held the world's fastest computing speed, may be used to shorten the time needed in regenerative medicine from several months, or even years, to several hours, according to the Riken Center of Developmental Biology and other institutions.

Researchers aim to create organs from human embryonic stem cells (ES cells) or induced pluripotent stem cells (iPS cells), but the length of time normally needed to accomplish this task is a problem.

The institutions hope to put regenerative medicine into practical use as soon as possible using iPS cells, a Japanese technology, and other cells, and this is where the supercomputer will come in.

Yoshiki Sasai, group director at the Riken Center, and other researchers are planning to use the K supercomputer to determine the best method to create organs from these cells.

The researchers successfully developed an optic cup, a basic part of the eye, from ES cells for the first time in the world. While it takes about six months to transform ES cells into an optic cup, the researchers spent about three years to find how to do this through trial and error.

Currently, it takes several years to complete basic experiments to transform ES cells or iPS cells into target organs, and in many cases the experiments fail to achieve their purpose.

Plans are under way to use the K supercomputer to develop new medicines, work out disaster prevention measures and conduct research on cosmic evolution and for other purposes.

Sasai and the other researchers, therefore, decided the supercomputer, which performs 10 quadrillion (or one kei in Japanese) calculations per second, would be ideal in completing basic experiments in a fraction of the time it now takes.

If the K supercomputer calculates mathematized data on divisions, growth and internal changes of iPS cells to which protein or certain kinds of genes are added, it will become possible to create target organs more effectively, according to the researchers.

Continued here:
K computer may be used in regenerative medicine

Posted in Regenerative Medicine | Comments Off on K computer may be used in regenerative medicine

Fertility hope in stem cell eggs

Posted: October 5, 2012 at 7:15 pm

Hopes of a cure for infertility in humans were raised Friday after Japanese stem cell researchers announced they had created viable eggs using normal cells from adult mice.

The breakthrough raises the possibility that women who are unable to produce eggs naturally could have them created in a test tube from their own cells and then planted back into their body.

A team at Kyoto University harvested stem cells from mice and altered a number of genes to create cells very similar to the primordial germ cells that generate sperm in men and oocytes -- or eggs -- in women.

They then nurtured these with cells that would become ovaries and transplanted the mixture into living mice, where the cells matured into fully-grown oocytes.

They extracted the matured oocytes, fertilised them in vitro -- in a test tube -- and implanted them into surrogate mother mice.

The resulting mice pups were born healthy and were even able to reproduce once they matured.

Writing in the US journal Science, which published the findings, research leader professor Michinori Saito said the work provided a promising basis for hope in reproductive medicine.

"Our system serves as a robust foundation to investigate and further reconstitute female germline development in vitro, not only in mice, but also in other mammals, including humans," he said.

Saito cautioned that this was not a ready-made cure for people with fertility problems, adding that a lot of work remained.

"This achievement is expected to help us understand further the egg-producing mechanism and contribute to clarifying the causes of infertility," he told reporters.

View original post here:
Fertility hope in stem cell eggs

Posted in Cell Medicine | Comments Off on Fertility hope in stem cell eggs

Multiple miRNA Markers Associated with Angiogenesis and Tissue Injury Repair Expressed in Cytori’s Cell Therapy

Posted: October 5, 2012 at 2:22 pm

SAN DIEGO--(BUSINESS WIRE)--

Cytori Therapeutics (CYTX) announced that three oral presentations related to its cell therapy are being presented today at the 10th annual International Federation for Adipose Therapeutics and Sciences meeting. The findings provide insights into the mechanisms-of-action for Cytoris cell therapy. One study identified high levels of micro-RNA (miRNA) markers in human tissue thought to play a role in the repair of tissue injury resulting from ischemia, or lack of blood flow. Two additional characterization and comparative analysis studies on human tissue reaffirmed cellular characteristics of Cytoris cell therapy and distinguished the safety, viability and cell make-up as compared to cell outputs derived from alternate approaches.

Results from all three studies have important implications for how the cells repair injured tissue and on the safety and viability of cell-based treatments derived from adipose tissue, said John Fraser, Ph.D., Chief Scientist of Cytori Therapeutics. Mechanisms identified in our miRNA analysis are consistent with our prior clinical and preclinical data, which suggest these mechanisms include angiogenesis, immune-modulation, and remodeling and wound repair. The miRNA study provides baseline data, which we can apply to our U.S. ATHENA clinical trial in refractory heart failure patients and other activities including our recently announced contract with BARDA for thermal burns.

In one study, miRNA profiles were assessed in adipose-derived stem and regenerative cells (ADRCs) derived from human tissue samples. The purpose was to determine which miRNA markers are expressed, miRNA variability from patient to patient, cellular functions of miRNA, and to establish a baseline miRNA population on healthy patients to compare against patients with a specific disease. Specifically, miRNA markers associated with angiogenesis, tissue remodeling and wound repair, and modulation of the immune response were found to be highly represented in ADRCs.

Our two additional characterization and comparative analysis studies evaluated alternate processing techniques and reaffirmed our proprietary enzyme-based process using Celution is the clear gold standard, added Dr. Fraser. If the composition of a cell population extracted from adipose tissue by an alternative process is not equivalent to Cytoris ADRC population, one cannot claim equivalence to ADRCs in terms of safety or efficacy in preclinical or clinical outcomes.

The characterization and comparative analysis studies reaffirmed the high cell yield and viability as well as the heterogeneity in Cytoris cell therapy approach. Cytoris cells are derived with a proprietary formulation of clinical grade enzymes which break up the connective tissue and which are removed at the end of the process. Cytoris cell mixture includes adipose-derived stem cells, based on the measure of colony forming units, and a high yield of CD34+ cells. By contrast, data in these studies showed that alternate approaches such as ultrasound or emulsification, contained little to no adipose-derived stem cells, a high concentration of red and white blood cells, and did not meet the key criteria for safe clinical use.

About Cytori

Cytori Therapeutics, Inc. is developing cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and repair soft tissue defects. Our scientific data suggest ADRCs improve blood flow, moderate the immune response and keep tissue at risk of dying alive. As a result, we believe these cells can be applied across multiple "ischemic" conditions. These therapies are made available to the physician and patient at the point-of-care by Cytori's proprietary technologies and products, including the Celution system product family. http://www.cytori.com

Cautionary Statement Regarding Forward-Looking Statements

This press release includes forward-looking statements regarding events, trends and business prospects, which may affect our future operating results and financial position. Such statements including our ability to apply this data to our ATHENA study and other projects are subject to risks and uncertainties that could cause our actual results and financial position to differ materially. Some of these risks and uncertainties include our history of operating losses, the need for further financing, inherent risk and uncertainty in the protection of intellectual property rights, regulatory uncertainties regarding the collection and results of, clinical data, dependence on third party performance, and other risks and uncertainties described under the "Risk Factors" in Cytori's Securities and Exchange Commission Filings, including its annual report on Form 10-K for the year ended December 31, 2011. Cytori assumes no responsibility to update or revise any forward-looking statements contained in this press release to reflect events, trends or circumstances after the date of this press release.

Read the original:
Multiple miRNA Markers Associated with Angiogenesis and Tissue Injury Repair Expressed in Cytori’s Cell Therapy

Posted in Cell Therapy | Comments Off on Multiple miRNA Markers Associated with Angiogenesis and Tissue Injury Repair Expressed in Cytori’s Cell Therapy

Baby Mice Born from Eggs Made from Stem Cells

Posted: October 5, 2012 at 10:24 am

Mouse pups from induced pluripotent stem cell-derived eggs; image courtesy of Katsuhiko Hayashi

Stem cells have been coaxed into creating everything from liver cells to beating heart tissue. Recently, these versatile cells were even used to make fertile mouse sperm, suggesting that stem cell technology might eventually be able to play a role in the treatment of human infertility. Now two types of stem cells have been turned into viable mouse egg cells that were fertilized and eventually yielded healthy baby mice. Details of this achievement were published online October 4 in Science.

Mouse oocytes; image courtesy of Katsuhiko Hayashi

Katsuhiko Hayashi, of Kyoto University's School of Medicine, were able to create the eggs with embryonic stem cells as well as with induced pluripotent stem cells (formed from adult cells). The team started with female embryonic stem cells and then coaxed them genetically to revert to an earlier developmental stage (primordial germ cell-like cells). These cells were blended with gonadal somatic cells, important in the development of sexual differentiation, to create "reconstituted ovaries." The researchers then transplanted these cultured assemblages into female mice (in either the actual ovary or the kidney) for safekeeping and to allow the stem cells to mature into oocytes in a natural environment.

Healthy adult mice from litter produced from induced pluripotent stem cell-based oocytes; image courtesy of Katsuhiko Hayashi

To test the eggs' fertility, the new oocytes were removed from the mice for an in vitro fertilization with mouse spermand then re-implanted into the female mice. The experimental females went on to bear normally developing and fertile offspring. The procedure was then also performed successfully with induced pluripotent stem cells from adult skin cells with similar results. "Our system serves as a robust foundation to investigate and further reconstitute female germline development in vitro," the researchers noted in their paper," not only in mice, but also in other mammals, including humans."

Follow Scientific American on Twitter @SciAm and @SciamBlogs. Visit ScientificAmerican.com for the latest in science, health and technology news. 2012 ScientificAmerican.com. All rights reserved.

Excerpt from:
Baby Mice Born from Eggs Made from Stem Cells

Posted in Stem Cell Videos | Comments Off on Baby Mice Born from Eggs Made from Stem Cells

Scientists Create Healthy Mice Using Eggs Made From Stem Cells [Science]

Posted: October 5, 2012 at 10:24 am

A team of Japanese scientists has managed to turn mouse stem cells into viable eggsthat can be inseminated and go on to produce normal, healthy mouse pups. The finding has massive implications for the development of infertility treatments in the future.

The team of researchers from Kyoto University has previously created fully grown adult mice using sperm created from stem cellsbut that's comparatively straightforward. Sperm, you see, are some of the simpler cells in the body: eggs are far more complex.

In this new study, published in Science, the researchers took embryonic stem cells, and induced pluripotent stem cells (iPSCs) from them. They then used a host of signaling molecules to slowly transform the iPSCs into egg precursors known as primordial germ cells. After further coddling in lab-grown ovary tissue, the cellsover the course of four weeksmatured into eggs.

The scientists fertilized these eggs and transplanted the resulting embryos in to foster mothers. A short while later, healthy offspring emerged, which went on to become fertile themselves. All in, it's a long and involved processbut, amazingly, it works.

The finding gives a useful glimpse into the processes at play during meiosis, the cell-division process which is peculiar to sex cells like eggs. But perhaps more interesting are the possibilities for the development of new infertility treatments in the future.

As ever, just because something's possible in a mouse doesn't mean it will necessarily work in a human model, but that won't stop the team trying: indeed, they're already starting to work with human stem cells instead. Expect a wait before you hear of this kind of technology being used in a clinical, as opposed to research, setting, though, because the ethical issues surrounding it will be close to impossible to settle. [Science via Nature]

Image by angeladellatorre under Creative Commons license

View post:
Scientists Create Healthy Mice Using Eggs Made From Stem Cells [Science]

Posted in Stem Cell Videos | Comments Off on Scientists Create Healthy Mice Using Eggs Made From Stem Cells [Science]

Life created for first time from eggs made from skin cells

Posted: October 5, 2012 at 10:24 am

London, October 5 (ANI): Using stem cells made from skin, a Japanese team has created healthy eggs that, once fertilised, grow into normal baby mice.

These babies later had their own babies, the BBC reported.

The team at Kyoto University used stem cells from two sources: those collected from an embryo and skin-like cells, which were reprogrammed, into becoming stem cells.

The first step was to turn the stem cells into early versions of eggs.

A "reconstituted ovary" was then built by surrounding the early eggs with other types of supporting cells that are normally found in an ovary. This was transplanted into female mice. Surrounding the eggs in this environment helped them to mature.

IVF techniques were used to collect the eggs, fertilise them with sperm from a male mouse and implant the fertilised egg into a surrogate mother.

"They develop to be healthy and fertile offspring," Dr Katsuhiko Hayashi, from Kyoto University, told the BBC.

Those babies then had babies of their own, whose "grandmother" was a cell in a laboratory dish.

If the same methods could be used in people then, it could help infertile couples have children and even allow women to overcome the menopause.

But experts say many scientific and ethical hurdles must be overcome before the technique could be adapted for people.

Visit link:
Life created for first time from eggs made from skin cells

Posted in Stem Cell Videos | Comments Off on Life created for first time from eggs made from skin cells

Page 2,627«..1020..2,6262,6272,6282,629..2,6402,650..»